PROMMUNE

Our technology is backed by more than 20 peer-reviewed publications covering its development and therapeutic use in humans and animals... Our platform technology consists of a pipeline of immunoactivator peptides that stimulate an immune response, while eliminating accompanying inflammatory activity. They can be used as activators, molecular adjuvants or conjugated to antigens to generate a wide range of immune responses to pathogens.

Also known as: Prommune Inc

Primary location: Overland Park United States